Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
MEI Pharma Inc
MEIPCurrent price
2.31 USD
-0.014 USD (-0.60%)
Last closed
2.30 USD
Company
www.meipharma.com
ISIN
US55279B2025
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
17 989 720 USD
Yield for 12 month
-39.71 %
1Y
3Y
5Y
10Y
15Y
MEIP
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. Address: 9920 Pacific Heights Blvd., San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
20.00 USDP/E ratio
–Dividend Yield
–Current Year
+65 297 000 USD
Last Year
+48 816 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+64 914 000 USD
Last Year
+47 001 000 USD
Current Quarter
–
Last Quarter
-3 776 000 USD
Key Figures MEIP
1 year
3 years
5 years
10 years
EBITDA
26 380 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
20.04 %
PEG Ratio
20.60
Return On Equity TTM
61.68 %
Wall Street Target Price
20.00 USD
Revenue TTM
65 297 000 USD
Book Value
4.96 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
48 816 000 USD
Earnings per share
-6.68 USD
Diluted Eps TTM
-6.68 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
27.23 %
Dividend Analytics MEIP
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History MEIP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
16.11.2023
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
17.04.2023
Stock Valuation MEIP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.39
Price Sales TTM
0.28
Enterprise Value EBITDA
-1.58
Price Book MRQ
0.72
Financials MEIP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MEIP
For 52 weeks
2.51 USD
6.52 USD
50 Day MA
2.85 USD
Shares Short Prior Month
63 464
200 Day MA
3.13 USD
Short Ratio
0.94
Shares Short
48 934
Short Percent
1.48 %
BeatStart